Fr. Emmanuel Files Opposition in SEC Fight over Ligand Pharmaceuticals (NASDAQ: LGND)

To read the full Opposition click here or view on Scribd below. "That is, the Commission promoted Ligand’s stock price in its Complaint, which was riddled with...